FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1191318270> ?p ?o ?g. }

• W1191318270 endingPage "743" @default.
• W1191318270 startingPage "731" @default.
• W1191318270 abstract "Tumor necrosis factor-alpha (TNF-α) antagonists have shown remarkable efficacy in psoriasis; however, the precise mechanisms of action of TNF-α blocking agents mainly focus on their neutralizing TNF-α and its anti-inflammatory effects. In this study, we generated a humanized anti-TNF-α monoclonal antibody (IBI303) and suggested a potential mechanism of anti-TNF-α therapy for psoriasis. The results of SPR and ELISA indicated that IBI303 has a good affinity to TNF-α. In vitro, it could suppress TNF-α-induced cytotoxicity in WEHI164 cells. In vivo, administration of IBI303 to K14-VEGF transgenic mice led to a significant treatment efficiency in psoriasis in a dose-dependent manner. IHC staining and cytokines–ELISA indicated that TNF-α inhibition strongly reduced inflammatory cells infiltration and pro-inflammatory cytokines release, accompanied by suppression of inflamed dermal blood vessels. Mechanistically, in order to explain the anti-angiogenesis effect of anti-TNF-α antibody, the production of cytokine in macrophage conditional medium was measured by ELISA. The result indicated that the massive secretion of TNF-α stimulated by LPS in RAW264.7 cell supernatant was markedly neutralized in a dose–response manner by IBI303, moreover, the expression of NF-κB p65 was down-regulated. Mouse endothelial cell tube formation assay showed that anti-TNF-α could inhibit blood vessels formation directly and indirectly. Collectively, our study suggested a kind of antipsoriatic mechanism of TNF-α inhibitors that is the dual inhibition of inflammation and angiogenesis." @default.
• W1191318270 created "2016-06-24" @default.
• W1191318270 creator A5002744113 @default.
• W1191318270 creator A5005893279 @default.
• W1191318270 creator A5011964734 @default.
• W1191318270 creator A5014781053 @default.
• W1191318270 creator A5015463546 @default.
• W1191318270 creator A5018073672 @default.
• W1191318270 creator A5021561362 @default.
• W1191318270 creator A5037014030 @default.
• W1191318270 creator A5038075549 @default.
• W1191318270 creator A5040562221 @default.
• W1191318270 creator A5049692788 @default.
• W1191318270 creator A5067937579 @default.
• W1191318270 creator A5076343086 @default.
• W1191318270 creator A5083147112 @default.
• W1191318270 creator A5085615634 @default.
• W1191318270 creator A5090403310 @default.
• W1191318270 creator A5090950891 @default.
• W1191318270 creator A5091386509 @default.
• W1191318270 date "2015-09-01" @default.
• W1191318270 modified "2023-09-29" @default.
• W1191318270 title "Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis" @default.
• W1191318270 cites W1505106591 @default.
• W1191318270 cites W1583798678 @default.
• W1191318270 cites W1782747004 @default.
• W1191318270 cites W1939997832 @default.
• W1191318270 cites W1965138135 @default.
• W1191318270 cites W1973302470 @default.
• W1191318270 cites W1973893754 @default.
• W1191318270 cites W1978081120 @default.
• W1191318270 cites W1978606965 @default.
• W1191318270 cites W1979065738 @default.
• W1191318270 cites W1986161286 @default.
• W1191318270 cites W1989219560 @default.
• W1191318270 cites W1989262688 @default.
• W1191318270 cites W1989777330 @default.
• W1191318270 cites W1991281300 @default.
• W1191318270 cites W1994435105 @default.
• W1191318270 cites W1994576750 @default.
• W1191318270 cites W2012097026 @default.
• W1191318270 cites W2016300251 @default.
• W1191318270 cites W2016934329 @default.
• W1191318270 cites W2028654839 @default.
• W1191318270 cites W2034133454 @default.
• W1191318270 cites W2038152129 @default.
• W1191318270 cites W2055654952 @default.
• W1191318270 cites W2061294496 @default.
• W1191318270 cites W2061600342 @default.
• W1191318270 cites W2063627867 @default.
• W1191318270 cites W2063640156 @default.
• W1191318270 cites W2073037264 @default.
• W1191318270 cites W2074360288 @default.
• W1191318270 cites W2082674570 @default.
• W1191318270 cites W2104902789 @default.
• W1191318270 cites W2107432039 @default.
• W1191318270 cites W2113114869 @default.
• W1191318270 cites W2115789412 @default.
• W1191318270 cites W2118378313 @default.
• W1191318270 cites W2122044177 @default.
• W1191318270 cites W2135787471 @default.
• W1191318270 cites W2136157736 @default.
• W1191318270 cites W2145544715 @default.
• W1191318270 cites W2151686792 @default.
• W1191318270 cites W2170138746 @default.
• W1191318270 cites W250723341 @default.
• W1191318270 cites W2561759163 @default.
• W1191318270 doi "https://doi.org/10.1016/j.intimp.2015.07.036" @default.
• W1191318270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26263167" @default.
• W1191318270 hasPublicationYear "2015" @default.
• W1191318270 type Work @default.
• W1191318270 sameAs 1191318270 @default.
• W1191318270 citedByCount "29" @default.
• W1191318270 countsByYear W11913182702015 @default.
• W1191318270 countsByYear W11913182702016 @default.
• W1191318270 countsByYear W11913182702017 @default.
• W1191318270 countsByYear W11913182702018 @default.
• W1191318270 countsByYear W11913182702019 @default.
• W1191318270 countsByYear W11913182702020 @default.
• W1191318270 countsByYear W11913182702021 @default.
• W1191318270 countsByYear W11913182702022 @default.
• W1191318270 countsByYear W11913182702023 @default.
• W1191318270 crossrefType "journal-article" @default.
• W1191318270 hasAuthorship W1191318270A5002744113 @default.
• W1191318270 hasAuthorship W1191318270A5005893279 @default.
• W1191318270 hasAuthorship W1191318270A5011964734 @default.
• W1191318270 hasAuthorship W1191318270A5014781053 @default.
• W1191318270 hasAuthorship W1191318270A5015463546 @default.
• W1191318270 hasAuthorship W1191318270A5018073672 @default.
• W1191318270 hasAuthorship W1191318270A5021561362 @default.
• W1191318270 hasAuthorship W1191318270A5037014030 @default.
• W1191318270 hasAuthorship W1191318270A5038075549 @default.
• W1191318270 hasAuthorship W1191318270A5040562221 @default.
• W1191318270 hasAuthorship W1191318270A5049692788 @default.
• W1191318270 hasAuthorship W1191318270A5067937579 @default.
• W1191318270 hasAuthorship W1191318270A5076343086 @default.
• W1191318270 hasAuthorship W1191318270A5083147112 @default.
• W1191318270 hasAuthorship W1191318270A5085615634 @default.

• next